Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related… Jun 8, 2021
Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange May 27, 2021
Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development… May 26, 2021
Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd May 20, 2021
Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer May 20, 2021
COMPASS Pathways plc announces financial results and business highlights for the Q1 2021 May 13, 2021
